Joong-won G. Park
Goyang, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 120 publications
A plain language summary of the CheckMate 9DW study: nivolumab in combination with ipilimumab for unresectable hepatocellular carcinoma (advanced liver cancer).
Journal: Future oncology (London, England)
Published: April 15, 2026
Second-Line and Subsequent Therapies after Atezolizumab Plus Bevacizumab Treatment in Hepatocellular Carcinoma: A Multicenter Prospective Cohort Study.
Journal: Gut and liver
Published: October 29, 2025
Characterization of Patients with Unresectable Hepatocellular Carcinoma in REFLECT Who Achieved Tumor Response or Alpha-Fetoprotein Response When Treated with Lenvatinib.
Journal: Liver cancer
Published: October 24, 2025
Nivolumab plus ipilimumab versus lenvatinib or sorafenib as first-line treatment for unresectable hepatocellular carcinoma (CheckMate 9DW): an open-label, randomised, phase 3 trial.
Journal: Lancet (London, England)
Published: December 09, 2024
Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.
Journal: Journal of hepatology
Published: February 16, 2024
Concurrent nivolumab and external beam radiation therapy for hepatocellular carcinoma with macrovascular invasion: A phase II study.
Journal: JHEP reports : innovation in hepatology
Published: November 17, 2023
Feasibility of additional radiotherapy in patients with advanced hepatocellular carcinoma treated with atezolizumab plus bevacizumab.
Journal: Journal of liver cancer
Published: March 20, 2023
Overview of Asian clinical practice guidelines for the management of hepatocellular carcinoma: An Asian perspective comparison.
Journal: Clinical and molecular hepatology
Published: March 09, 2023
Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis.
Journal: Clinical and molecular hepatology
Published: February 27, 2023
A case of successful surgical treatment for peritoneal seeding of hepatocellular carcinoma after radiotherapy and atezolizumab plus bevacizumab combination treatment.
Journal: Journal of liver cancer
Published: January 12, 2023
Sorafenib for 9,923 Patients with Hepatocellular Carcinoma: An Analysis from National Health Insurance Claim Data in South Korea.
Journal: Gut and liver
Published: November 19, 2022
Last Updated: 09/26/2026